Moleculin Biotech, Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Apr 3, 2017
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia Mar 22, 2017
Moleculin Presents Preclinical Data of Novel Inhibitor of Glycolysis at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Dec 13, 2016
Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2016 Nov 21, 2016
